Literature DB >> 18055122

Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

B D Armstrong1, C Abad, S Chhith, G Cheung-Lau, O E Hajji, H Nobuta, J A Waschek.   

Abstract

Peripheral nerve injury models are used to investigate processes that can potentially be exploited in CNS injury. A consistent change that occurs in injured peripheral neurons is an induction in expression of pituitary adenylyl cyclase activating peptide (PACAP), a neuropeptide with putative neuroprotective and neuritogenic actions. PACAP-deficient mice were used here to investigate actions of endogenous PACAP after facial nerve injury. Although motor neuron survival after axotomy was not significantly different in PACAP deficient vs. wild type mice, recovery of axon regeneration after crush injury was significantly delayed. The impaired regeneration was associated with 8- to 12-fold increases in gene expression of proinflammatory cytokines tumor necrosis factor-alpha, interferon-gamma, interleukin (IL) -6, and a 90% decrease in the anti-inflammatory cytokine IL-4 at the injury site. Similar cytokine changes and an increased microglial response were observed in the brainstem facial motor nucleus. Because immunocompromised animals such as SCID mice are known to exhibit peripheral nerve regeneration defects, the observations raise the novel hypothesis that PACAP is critically involved in a carefully controlled immune response that is necessary for proper nerve regeneration after injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055122      PMCID: PMC2245872          DOI: 10.1016/j.neuroscience.2007.09.084

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

1.  Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation.

Authors:  Y Zhang; N Danielsen; F Sundler; H Mulder
Journal:  Neuroreport       Date:  1998-08-24       Impact factor: 1.837

2.  Differential T cell response in central and peripheral nerve injury: connection with immune privilege.

Authors:  G Moalem; A Monsonego; Y Shani; I R Cohen; M Schwartz
Journal:  FASEB J       Date:  1999-07       Impact factor: 5.191

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.

Authors:  Hideki Kato; Atsushi Ito; Jun Kawanokuchi; Shijie Jin; Tetsuya Mizuno; Kosei Ojika; Ryuzou Ueda; Akio Suzumura
Journal:  Mult Scler       Date:  2004-12       Impact factor: 6.312

4.  The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones.

Authors:  Victor Suarez; Orlando Guntinas-Lichius; Michael Streppel; Shota Ingorokva; Maria Grosheva; Wolfram F Neiss; Doychin N Angelov; Lars Klimaschewski
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

5.  Pituitary adenylate cyclase-activating polypeptide promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo: comparison with effects of nerve growth factor.

Authors:  N Takei; E Torres; A Yuhara; H Jongsma; C Otto; L Korhonen; Y Abiru; Y Skoglösa; G Schütz; H Hatanaka; M V Sofroniew; D Lindholm
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

6.  Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus.

Authors:  X Zhou; W I Rodriguez; R A Casillas; V Ma; J Tam; Z Hu; V Lelievre; A Chao; J A Waschek
Journal:  J Neurosci Res       Date:  1999-09-15       Impact factor: 4.164

7.  Lymphocyte regulation of neuropeptide gene expression after neuronal injury.

Authors:  Brian D Armstrong; Zhongting Hu; Catalina Abad; Miya Yamamoto; Williams I Rodriguez; Jennifer Cheng; Jimmy Tam; Rosa P Gomariz; Paul H Patterson; James A Waschek
Journal:  J Neurosci Res       Date:  2003-10-15       Impact factor: 4.164

Review 8.  The facial nerve axotomy model.

Authors:  Linda B Moran; Manuel B Graeber
Journal:  Brain Res Brain Res Rev       Date:  2004-03

9.  Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide.

Authors:  Carmine Guirland; Kenneth B Buck; Jean A Gibney; Emanuel DiCicco-Bloom; James Q Zheng
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

10.  Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.

Authors:  G Raivich; L L Jones; C U Kloss; A Werner; H Neumann; G W Kreutzberg
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

View more
  49 in total

1.  Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.

Authors:  Laszlo Mester; Krisztina Kovacs; Boglarka Racz; Izabella Solti; Tamas Atlasz; Krisztina Szabadfi; Andrea Tamas; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

2.  Transient changes in spinal cord glial cells following transection of preganglionic sympathetic axons.

Authors:  Aminata P Coulibaly; Lori G Isaacson
Journal:  Auton Neurosci       Date:  2012-01-29       Impact factor: 3.145

3.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

4.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

5.  Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema.

Authors:  Zsuzsanna Helyes; Jozsef Kun; Nora Dobrosi; Katalin Sándor; Jozsef Németh; Aniko Perkecz; Erika Pintér; Krisztina Szabadfi; Balazs Gaszner; Valeria Tékus; Janos Szolcsányi; Martin Steinhoff; Hitoshi Hashimoto; Dora Reglődi; Tamas Bíró
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

6.  Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.

Authors:  Sayako Nonaka; Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Teruko Takano-Yamamoto
Journal:  Cell Mol Neurobiol       Date:  2013-06-26       Impact factor: 5.046

7.  Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.

Authors:  Lee E Eiden; Babru Samal; Matthew J Gerdin; Tomris Mustafa; David Vaudry; Nikolas Stroth
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  Intrinsic response of thoracic propriospinal neurons to axotomy.

Authors:  Justin R Siebert; Frank A Middelton; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2010-06-04       Impact factor: 3.288

9.  Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells.

Authors:  Johanna Mäkelä; Raili Koivuniemi; Laura Korhonen; Dan Lindholm
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons.

Authors:  Beth A Habecker; Hilary Hyatt Sachs; Hermann Rohrer; Richard E Zigmond
Journal:  Dev Neurobiol       Date:  2009-05       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.